Contact Us

You are registering for:

Columbia Laboratories Enters Into Purchase and Collaboration Agreement with Watsom Pharmaceuticals for Progesterone Franchise
Watson to acquire rights to CRINONE® and PROCHIEVE® and 11.2 million shares of common stock for upfront and milestone payments of up to $92.5 million plus royalties Also announces contingent agreements to retire debt Investor conference call at 8:30 AM ET today

First Name:*
Last Name:*
Company:
Job Title:
Email:*
Phone:
Fax:
Do you wish to start receiving Columbia's press releases?
Enter the code shown: